Physician profile
Bruce Scudday
NPI 1073574943
$3,963.67
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $48.59 · 2021: $2,343 · 2022: $462 · 2023: $628 · 2024: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $583 · Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $582.95 |
| Food and Beverage | $289.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,520.00 | 2021 | |
| Treace Medical Concepts, INC. | $923.53 | 2022-2024 | |
| Paragon 28, INC. | $805.76 | 2021-2024 | Precision Mis Bunion |
| Sanara Medtech INC. | $152.06 | 2022 | |
| Integra Lifesciences Corporation | $151.19 | 2019-2020 | |
| Smith+Nephew, INC. | $108.02 | 2020-2023 | Collagenase Santyl, Regranex |
| Depuy Synthes Sales INC. | $97.54 | 2019 | |
| Stryker Corporation | $52.62 | 2024 | Actishield |
| Misonix INC | $51.09 | 2021 | |
| Horizon Therapeutics Plc | $26.03 | 2023 | Krystexxa |
| Osteomed LLC | $21.84 | 2022 | |
| Djo, LLC | $19.77 | 2019 | |
| Bioventus LLC | $17.51 | 2021 | |
| Grt US Holding, INC. | $16.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Scudday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.